Clinical Trial: A Study of Cyclophosphamide, Methotrexate, Fluorouracil (CMF) for People With Breast Cancer

U.S., Aug. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07768436) titled 'A Study of Cyclophosphamide, Methotrexate, Fluorouracil (CMF) for People With Breast Cancer' on Aug. 12.

Brief Summary: The purpose of this study is to find out if it is practical (feasible) to give dose-dense CMF (cyclophosphamide, methotrexate, and fluorouracil) in two standard chemotherapy regimens in people with breast cancer, age 70 and older.

Study Start Date: Aug. 11

Study Type: INTERVENTIONAL

Condition: Adenocarcinoma of the Breast Breast Cancer Triple Negative Breast Cancer

Intervention: DRUG: CMF Regimen

CMF regimen: Cyclophosphamide, Methotrexate, and Fluorouracil

DRUG: Paclitaxel

Paclitaxel will be administered ...